LDOS Shorts Retreat as Stock Extends Its Rally

Leidos Holdings enters its November 3 earnings week with short sellers continuing to pull back, borrow conditions exceptionally loose, and the stock up 9.4% over the past seven days to close at $139.64.

Short interest has dropped another 8.7% over the week to 3.3% of free float, representing roughly 4.2 million shares. That extends the retreat documented in the October 21 note, when SI stood at 3.6% of float and roughly 4.56 million shares. The direction of travel has been consistent: shorts have been trimming into the rally rather than pressing against it. The borrow market tells the same story. Cost to borrow eased a further 7.3% over the week to 0.43%, already low territory. Availability is essentially unconstrained, at levels that place no practical limit on new short positions. The ORTEX short score has drifted down to 35.3, continuing a gentle decline from 36.4 ten days ago, all of which adds up to a lending market with little tension on either side.

Options positioning is mildly constructive. The put/call ratio came in at 0.47, slightly below its 20-day average of 0.50, with a z-score of roughly -0.48. That is close to neutral and a meaningful shift from the elevated put demand noted in the October 12 note. Options traders are not pressing for downside protection with earnings six days out, which is the more notable fact given how much the stock has moved.

The analyst community remains cautious, though the worst of the target-cut wave appears to have passed. In early October, JP Morgan downgraded to Neutral from Overweight and cut its target to $142, while Citigroup and Jefferies both trimmed targets sharply. The mean consensus target now sits at around $152, implying roughly 8% above current levels. The bull case rests on the funded backlog growth, a 1Q26 EPS beat of $3.13 against $2.90 consensus, and the Entrust acquisition adding incremental revenue. Bears point to operating income declines across multiple segments, dependence on government appropriations cycles, and 2027 budget visibility concerns. The PE has re-rated to 11.2x over the past month, up 1.5 turns over 30 days, reflecting the stock's recovery from its mid-October lows. EV/EBITDA at 8.9x is broadly in line with where it has been trading.

The peer group moved in similar fashion over the week. CACI gained 9.6%, Booz Allen Hamilton added 11.2%, and KBR rose 9.2%. Leidos matched the sector median almost exactly, suggesting the week's move was largely a sector-wide re-rating rather than a company-specific event. Broadridge Financial was the outlier in the peer basket, falling 1.6% over the same period.

Wikipedia attention for Leidos has spiked to a z-score of 2.0 against its own 90-day history, the highest retail attention reading in the dataset window. That kind of elevated interest typically appears around anticipated events, and with the November 3 print now six days away, the data point fits the pattern. The prior earnings release in August produced a 6.8% one-day gain and an 18.7% five-day move, the only recent comparable in the dataset. How the Q3 numbers stack up against the raised full-year guidance issued after that August beat is the number worth watching most closely next week.